Renasant Bank’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $412K | Sell |
2,222
-3,187
| -59% | -$592K | 0.28% | 98 |
|
|
2025
Q1 | $1.13M | Sell |
5,409
-1,919
| -26% | -$402K | 0.75% | 37 |
|
|
2024
Q4 | $1.3M | Buy |
7,328
+210
| +3% | +$37.3K | 0.84% | 34 |
|
|
2024
Q3 | $1.41M | Sell |
7,118
-658
| -8% | -$130K | 0.92% | 30 |
|
|
2024
Q2 | $1.33M | Sell |
7,776
-1,468
| -16% | -$252K | 0.92% | 36 |
|
|
2024
Q1 | $1.68M | Sell |
9,244
-906
| -9% | -$165K | 1.2% | 15 |
|
|
2023
Q4 | $1.57M | Buy |
10,150
+1,066
| +12% | +$165K | 1.25% | 12 |
|
|
2023
Q3 | $1.35M | Buy |
9,084
+1,014
| +13% | +$151K | 1.14% | 14 |
|
|
2023
Q2 | $1.09M | Sell |
8,070
-1,498
| -16% | -$202K | 0.89% | 29 |
|
|
2023
Q1 | $1.52M | Sell |
9,568
-495
| -5% | -$78.9K | 1.18% | 15 |
|
|
2022
Q4 | $1.63M | Sell |
10,063
-489
| -5% | -$79K | 1.23% | 13 |
|
|
2022
Q3 | $1.42M | Buy |
10,552
+1,435
| +16% | +$193K | 1.25% | 16 |
|
|
2022
Q2 | $1.4M | Buy |
9,117
+1,337
| +17% | +$205K | 1.14% | 17 |
|
|
2022
Q1 | $1.26M | Buy |
7,780
+1,761
| +29% | +$285K | 0.85% | 29 |
|
|
2021
Q4 | $815K | Buy |
6,019
+1,310
| +28% | +$177K | 0.55% | 47 |
|
|
2021
Q3 | $508K | Sell |
4,709
-411
| -8% | -$44.3K | 0.4% | 81 |
|
|
2021
Q2 | $576K | Buy |
5,120
+40
| +0.8% | +$4.5K | 0.44% | 74 |
|
|
2021
Q1 | $549K | Sell |
5,080
-729
| -13% | -$78.8K | 0.44% | 69 |
|
|
2020
Q4 | $622K | Buy |
+5,809
| New | +$622K | 0.51% | 55 |
|